MESNA

Description

Mesna – Protective Agent for Chemotherapy-Induced Urotoxicity

Mesna (sodium 2-mercaptoethanesulfonate) is a prescription uroprotective agent used alongside certain chemotherapy drugs such as ifosfamide and cyclophosphamide. Its primary role is to prevent hemorrhagic cystitis, a serious bladder complication caused by toxic metabolites of these chemotherapy agents. Mesna binds to acrolein, the toxic byproduct, neutralizing its harmful effects and protecting the urinary tract.

At Oncomed Pharmacy, we supply high-quality Mesna injections and tablets from trusted manufacturers, ensuring patients receive safe and effective protection during cancer treatment.

________________________________________

Key Features of Mesna

• Indications:

o Prevention of hemorrhagic cystitis caused by ifosfamide and high-dose cyclophosphamide

o Supportive care in oncology to reduce chemotherapy-induced bladder toxicity

• Formulations: Available as injectable solution for intravenous use and oral tablets.
• Mechanism of Action: Thiol compound that binds to urotoxic metabolites (like acrolein) in the bladder, rendering them harmless.
• Patient Benefit: Enhances chemotherapy safety, allowing patients to receive full therapeutic doses with reduced risk of complications.

________________________________________

Why Buy Mesna from Oncomed Pharmacy?

• 100% genuine and quality-assured uroprotective medicine.
• Available in both oral and injectable forms.
• Affordable pricing with secure countrywide delivery.
• Trusted oncology pharmacy specializing in chemotherapy supportive medicines.

________________________________________

Uses of Mesna

• Oncology Supportive Care:

o Standard of care for patients receiving ifosfamide chemotherapy.

o Prevents bladder damage in cyclophosphamide-based regimens.

• Helps ensure patient safety during aggressive chemotherapy treatments.

________________________________________